LSD Autism Treatment: New Paths for Brain Synchronization

0 comments

1. Introduction

For the past few decades psychedelics have been back in the scientific spotlight because of their potential to treat many mental health conditions. Among the psychedelics getting attention LSD stands out because of its intricate brain function interaction. Once notorious for its association with the 1960s counter culture. But modern research is showing psychedelics could be a game changer for treating depression to anxiety disorders.

One of the most interesting paths is the effect of LSD on brain synchronization—specifically how it makes the brain sync with others and therefore better social bonding. This has led to research into the use of psychedelics to address the social deficits of autism spectrum disorder (ASD). In one study LSD was given to dogs to see how the psychedelic compound affects brain synchronization and that could be used to develop future autism treatments. This could be used to help alleviate some of the social difficulties of autism and explore the potential benefits of psychedelics in improving social interaction and emotional well-being.

In this article we will look into LSD and its history as well as its modern day research and its applications for autism spectrum disorder. We will explore the intersection of neuroscience, mycology, psychedelic assisted therapies and the ethics of this new field of research.

2. Understanding Autism Spectrum Disorder

Autism Spectrum Disorder (ASD) is a complex neurodevelopmental condition that affects communication, social interaction, and behavior. It is characterized by difficulties in verbal and non-verbal communication, social interaction, and repetitive behaviors. ASD is a spectrum disorder, meaning that it affects individuals to varying degrees and in different ways.

Definition and Characteristics of Autism

ASD is defined by the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) as a persistent deficit in social communication and social interaction across multiple contexts, including social-emotional reciprocity, nonverbal communicative behaviors, and developing and maintaining relationships. The characteristics of autism can vary widely, but common traits include difficulties with eye contact, facial expressions, and body language, as well as repetitive behaviors and interests. These challenges in social interaction can significantly impact the quality of life for individuals with autism, making it crucial to explore new therapeutic avenues.

Current Treatment Options and Limitations

Current treatment options for ASD include behavioral therapies, such as Applied Behavior Analysis (ABA) and Occupational Therapy (OT), as well as medications to manage symptoms such as anxiety and hyperactivity. While these treatments can be beneficial, they often have limitations and may not address the underlying causes of ASD. Behavioral therapies require significant time and resources, and medications can have side effects. This highlights the need for further research to develop more effective and personalized therapies that target the root biological mechanisms of ASD.

3. The Biology of Autism

The biology of autism is complex and not yet fully understood. However, research suggests that it involves abnormalities in brain structure and function, particularly in regions involved in social communication and behavior.

Serotonergic Hypothesis and Its Implications

One theory is that autism is related to abnormalities in the serotonergic system, which is involved in regulating mood, appetite, and sleep. The serotonergic hypothesis suggests that individuals with autism have altered serotonin levels and receptor function, which may contribute to their symptoms. This theory has significant implications for the development of new treatments, such as medications that target the serotonergic system. By understanding how serotonin receptors function differently in individuals with autism, researchers can explore new therapeutic potential to alleviate some of the social and communication difficulties associated with the spectrum disorder.

By maintaining a consistent tone and style, these new sections should integrate smoothly into the existing article, providing a comprehensive overview of autism spectrum disorder and its biological underpinnings while setting the stage for the discussion on LSD and brain synchronization.

2. LSD and its Medical History

LSD’s medical journey began in 1938 when Swiss chemist Albert Hofmann first synthesised the compound at Sandoz Laboratories. For several years LSD was being used in psychiatry for its profound hallucinogenic effects which were thought to give insights into the workings of the mind. In the 1950s and early 60s researchers were looking into LSD as a treatment for schizophrenia, alcoholism and even existential anxiety in terminally ill patients.

The compound’s ability to induce altered states of consciousness made it very interesting to mental health professionals. Early research suggested LSD therapy could give patients emotional clarity or allow them to revisit traumatic experiences from a new perspective and therefore resolve deep psychological issues.

But as LSD became associated with the 1960s counter culture it fell out of favour in the medical community and mainstream culture. Psychedelic therapy was shut down because of its association with recreational use and anti-establishment movements and the substance was classified as a Schedule I drug with no medical benefits.

Fast forward to the 21st century LSD along with other psychedelics like psilocybin and MDMA are being researched again thanks in part to the advocacy of leading psychiatrists and neuroscientists and the growing understanding of brain plasticity and mental health conditions. Today many scientists think LSD has untapped potential to treat psychiatric conditions like depression, anxiety and post traumatic stress disorder (PTSD). The move towards psychedelic therapy is moving from the fringes back into the mainstream and autism spectrum disorder could be next. Studies have shown that substances like MDMA can significantly reduce social anxiety among autistic adults, suggesting potential benefits for social functioning and decreasing anxiety during social interactions.

3. The Research: Why Dogs and LSD?

Using dogs as test subjects in psychedelic research might seem unusual at first. Most biological and neurological research that aims to be translated into human treatments use rats or non-human primates. But dogs bring something to the table that rodents and primates don’t—an innate and complex social structure that mirrors humans’. Like humans dogs are social animals that live in hierarchies, bond and communicate through non-verbal cues during interactions. They have similar brain structures that enable these social behaviors.

The study involved administering LSD to dogs to investigate its effect on brain synchrony. They were trying to tap into the social dynamic. They monitored the dogs’ brain activity and behaviour before and after the LSD. They were interested in how LSD affects brainwave synchrony—a phenomenon linked to cooperation and bonding between social beings.

Brain synchrony is essential for social interactions and is impaired in many disorders including autism. Autism spectrum disorder is characterised by difficulties in social communication and interaction which are closely linked to how the brain processes and synchronises external social cues. By studying how LSD affects dogs’ brain function during interactions they hoped to translate this into a framework for human studies and potentially treat autism symptoms. Ongoing research is critical for developing improved diagnostic tools and interventions, as well as exploring the efficacy and safety of these treatments for individuals with ASD.

Brain Synchrony and Social Interaction

To understand this research you need to understand how brain synchrony works. Brain synchrony is the precise alignment or coordination of brainwaves between two or more people during various social interactions. When two people share an experience, look into each other’s eyes or listen to a conversation their brainwave patterns synchronise. This often results in mutual empathy, harmonious social cues and deeper emotional exchange.

For neurotypical people brain synchrony is essential for meaningful relationships and understanding subtle social signals. Synchrony helps us tune into each other’s emotions, intentions and moods and is the foundation for things like empathy and cooperation. But for people on the autism spectrum this process often breaks down or works differently.

Autism is characterised by difficulties with understanding and responding to social cues like facial expressions or body language. Research has shown that people with autism have less brainwave synchrony during social interactions which is why they often struggle to connect with others.

Given the importance of brain synchrony in social communication any compound that can enhance this synchrony could change the way we treat social deficits in autism. The empathogenic and prosocial effects of psychedelic compounds, such as LSD, psilocybin, and DMT, have shown potential in enhancing social behavior and emotional recognition in individuals with autism. By studying LSD’s effect on brain synchrony in dogs they are laying the groundwork to potentially use psychedelics to overcome these communication barriers.

5. LSD’s Effect on Synchrony: The Results

The preliminary results from the dog LSD study are encouraging, highlighting the potential therapeutic benefits of psychedelics. After LSD the subjects had better social interactions and more importantly brainwave synchrony with human participants and other dogs. This increased social synchrony was seen in improved attention, more eye contact and longer bonding behaviour. Brainwave analysis showed that certain frequency bands involved in social bonding became more prominent after LSD.

But what does this mean? For people with autism brain synchrony issues can manifest as difficulties with non-verbal communication, emotional reciprocity, attention to social stimuli and interpreting social nuances all of which impact quality of life. If LSD does synchronise then it could help people to have more fluid and harmonious social interactions.

It’s important to note that these are preliminary results and only apply to a small dog study. But the research points to a previously unknown link between brain coherence and psychedelics which could be explored further in human studies. It’s too early to say that LSD can “cure” or even treat autism social impairments but it’s possible that psychedelics could provide new tools to strengthen brain functions related to social bonding.

Psychedelics and Individuals with Autism: Further Investigation

Given what we are learning about brain synchrony it’s tempting to wonder if LSD or other psychedelics could help with the social difficulties of autism. Research so far has focused on psychedelics’ ability to induce empathy, openness and emotional connection which could directly address the core issues in social interaction for people with ASD.

But there are several challenges to consider. Firstly people with autism have unique neurological complexities that make a blanket application of psychedelic treatment less straightforward. The effects of psychedelics can be unpredictable and could be very different between neurotypical people and those with ASD due to fundamental differences in brain structure and function. And the psychedelic experience is highly subjective which raises questions about consistency and safety of such treatments especially in vulnerable populations. Additionally, it is crucial to acknowledge the potential risks involved in administering psychedelics to individuals with autism to ensure safety and effectiveness in treatment protocols.

But the most promising aspect of psychedelic research in autism is microdosing – administering psychedelics in tiny amounts that don’t induce a full blown hallucinogenic experience but still affect brain chemistry at a subtler level. Microdosing LSD or other psychedelics could be a way to enhance synchrony without overwhelming the cognitive system or introducing psychological stress. This balanced approach has yet to be tested in large human trials but it’s definitely worth exploring.

And if future research shows that LSD can synchronise in human populations it could be paired with other treatments. For example LSD treatment could be combined with behavioural therapy to create a more holistic approach to managing autism symptoms.

7. The Ethics of Psychedelics in Research and Treatment

Ethics are important as research into psychedelics and their medical applications moves forward. Since the use of psychedelics like LSD, psilocybin and MDMA is still heavily regulated and in many places illegal using these substances requires laboratory controls and ethical oversight. When working with animals like the dogs in this study it’s essential that researchers follow strict ethical guidelines to minimize harm and treat the animals with respect and care.

On top of the general animal research ethics the use of psychedelics for autism adds another layer of complexity. ASD affects children disproportionately which makes administering substances like LSD to younger populations even more complicated. Long term safety studies are essential to ensure the developing brain is not harmed by these treatments. Anecdotal evidence from personal experiences and testimonials suggests potential benefits of psychedelics for individuals with autism spectrum disorder, but it is primarily subjective and should be approached with caution due to the lack of extensive scientific validation. Robust parental consent procedures and multidisciplinary ethical review boards would need to be part of any rollout of psychedelics as a treatment for autism.

Clinical settings would also need to have protocols in place to manage any adverse psychological effects that may occur during psychedelic assisted therapy. Trained mental health professionals would need to oversee psychedelic treatments given the psychological unpredictability of hallucinogens. And if psychedelics are part of ASD treatment programs access would need to be equitable to not marginalise any patient groups.

8. Psychedelics Beyond LSD: Psilocybin, Mushrooms and Autism

While we have been focusing on LSD so far it’s worth noting that other psychedelics might have similar or even better potential for autism treatment. Psilocybin derived from certain species of mushrooms is another well known psychedelic that is gaining traction in medical research. Like LSD psilocybin can induce altered states of consciousness, promote emotional openness, increase empathy and interestingly enhance brain plasticity.

Currently there are clinical trials for psilocybin for major depressive disorder and panic attacks so the gap between this research and autism treatment might be shorter than we think. Psilocybin works on serotonin receptors in a similar way to LSD which could explain its ability to regulate mood, enhance emotional resilience and potentially synchronise the brain.

One advantage of psilocybin over LSD is its milder and less intense effects. LSD is often more potent and longer lasting whereas psilocybin is shorter and less taxing. Psilocybin could be more suitable for therapeutic settings. Some research has shown that psilocybin can help people with enduring anxiety or depression gain new insights into their condition during sessions which could be similar for people with autism in terms of social cognition.

As more is discovered about how psychedelics work in the brain it’s likely other psychedelic compounds beyond LSD will be in the spotlight. The potential benefits and implications of using autism and lsd psychedelics are also being explored, emphasizing the need to understand their effects, risks, and future directions for treatment.

9. Mycology and Mental Health and Wellness

The interest in psychedelics is part of a broader trend towards holistic and natural approaches to treatment and mycology (the study of fungi) is leading the way. Historically fungi weren’t considered sources of potent therapeutic agents beyond simple nutrition but modern science is re-examining both psychedelic and non-psychedelic mushrooms for their brain benefits.

For example Lion’s Mane a non-psychedelic fungus has been shown to be neuroprotective. Studies have shown Lion’s Mane promotes neurogenesis (growth of new brain cells) and supports cognitive functions like memory retention and mental clarity. This could be huge for people with neurological conditions like autism who may need non-psychedelic ways to boost brain function.

Reishi and Cordyceps two other non-psychedelic mushrooms are being researched for their ability to modulate stress response and boost immune health which are key to both mental and physical well being. While these functional mushrooms don’t have the same consciousness altering effects as psilocybin they are growing in popularity in the wellness industry as natural cognitive enhancers that can be used in conjunction with other treatments.

As the intersection of wellness, mycology and mental health deepens it’s worth considering how the knowledge and techniques developed in the psychedelic space will converge with the broader field of mushroom based treatments. While many of these products are still in the speculative or early research phase interest and investment in mycology suggests it could be a major player in future mental health treatments.

The Bigger Picture of Psychedelic Treatments: Therapeutic Potential and Where Research is Going

Psychedelic research has come a long way in recent years and given the growing body of evidence for its neuropsychological benefits it will likely continue to progress. While LSD is dominating the conversation around brain synchronisation and social enhancement the field doesn’t stop there. Researchers are always looking at other psychedelics including natural compounds like psilocybin, synthetic compounds like MDMA and dissociative agents like ketamine all of which are emerging as potential treatments for various mental health conditions.

For example MDMA (ecstasy) is being researched as a potential treatment for PTSD under the umbrella of “MDMA-assisted therapy”. It allows patients to revisit traumatic memories in a therapeutic setting and release and resolve trauma. This could be adapted to help people with autism safely open up new emotional and social connections.

Ketamine another compound commonly associated with recreational use is also being researched as a treatment for severe depression and anxiety and has been shown to reduce symptoms when other drugs have failed. The versatility and multiple uses of these compounds combined with their ability to manipulate the brain’s ability to learn, adapt and build new connections means they could be a key part of autism treatments.

In the next few decades we will see more of these compounds in autism research and potentially more targeted treatments for individuals on the spectrum. With careful clinical trials, individualised dosing and integrated psychological support systems psychedelics could become an accepted part of mental health treatments and revitalize treatment for complex conditions like autism.

11. Mycology and Psychedelics: Common Ground

As both psychedelics and functional mushrooms research grows, the two fields are starting to intersect. Many companies focused on non-psychedelic mushrooms will invest in psychedelic research once the regulations allow. These interdisciplinary approaches will leverage fungi’s health benefits and create new synergies in the wellness space.

Imagine a world where companies making Lion’s Mane supplements fund psychedelic research, studying the health benefits of all fungi. The combination of the wellness industry and emerging clinical research will push these once fringe treatments into the mainstream.

If psychedelics like psilocybin and LSD are legalized for therapeutic use in clinics, it’s not hard to imagine a regulatory framework where natural supplements and psychedelics are prescribed together, for specific neurological functions. Whether these breakthroughs are for autism, depression, anxiety or other mental health issues, it’s a big frontier.

Clinical Trials: Risks and Cautions

Despite the potential, psychedelics are not a magic bullet. They are powerful substances that affect the brain in unpredictable ways and for some individuals, especially those with pre-existing psychiatric conditions, they can cause a range of adverse effects, paranoia, anxiety or even psychosis. Any exploration into using psychedelics for autism or other treatments must take these risks into account. Anecdotal reports highlight promising yet informal observations regarding the therapeutic effects of psychedelics on autism spectrum disorder (ASD), but they underscore the need for more rigorous scientific research.

And psychedelics have been associated with recreational use and in many cases, their use is illegal in some places. As research advances, more strict guidelines will need to be put in place to ensure these treatments are administered in safe and controlled environments with proper medical supervision.

Also to consider is the individual variability in how people respond to psychedelics. Environment, mental state, prior experiences, and even genetic makeup can all impact how psychedelics affect individuals, making the treatment not a straightforward process. This variability is why individual assessment and care is so important in planning treatments.

While the research is promising, we must proceed with caution. Standardizing dosages, protocols for adverse reactions and long term studies on their effects are all important variables that need to be addressed before these treatments can go mainstream.

13. Alternative Therapies for Autism: Where Mushrooms and Natural Solutions Fit In

In addition to the psychedelics, interest in other natural therapies and interventions for autism, especially non-psychedelic mushrooms is also growing. As mentioned earlier, Lion’s Mane is at the top of the list for those looking for natural ways to support brain health due to its neuroprotective properties and potential to induce neurogenesis. Lion’s Mane is available in supplement form and is being researched for cognitive disorders and emotional regulation.

Reishi and Cordyceps have shown to reduce stress and support immune function which could benefit individuals with autism whose stress responses and physiological imbalances often worsen social difficulties. For individuals or families looking to explore natural treatment options, mushroom supplements are a non-invasive, drug free approach that can complement behavioral and psychological therapies.

Also these functional mushrooms can be used as add-ons to future psychedelic treatment plans so patients can get support from multiple angles. Eventually these alternative treatments will be studied alongside conventional treatments and may become part of a comprehensive, multi-faceted approach to managing autism symptoms.

14. Conclusion: The Uncertain but Promising Road of Psychedelics for Autism Treatment

The research on psychedelics for autism treatment is still in its infancy but the early results are promising. Studies like the one on LSD and brain synchronization in dogs show that psychedelics can improve social bonding and communication, two areas where individuals with autism struggle. These findings give us hope that one day psychedelics can be a powerful tool to enhance social and cognitive functions for individuals on the spectrum.

But along with the promise there are important considerations around safety, ethics and individual variability. If psychedelics are to be part of autism treatment in the future they must be administered in controlled, safe environments and subjected to clinical trials to ensure both efficacy and safety. Also ethical discussions around using these substances especially on younger populations will require careful and nuanced thinking.

It’s also important that psychedelic research continues alongside other alternative therapies like non-psychedelic mushrooms like Lion’s Mane and Reishi which could also play a big role in treatment and brain health. Whether through natural means, therapeutic intervention or a combination of both the landscape of autism treatment is about to change.

Summary

LSD and Psychedelic Research: LSD and other psychedelics are being researched again for their therapeutic potential especially for mental health disorders like depression and PTSD. Research on LSD and brain synchronization could be useful for understanding and potentially treating autism spectrum disorder (ASD).
Brain Synchronization and Autism: Brain synchronization or the alignment of brainwave patterns between individuals during social interaction is key to communication. In individuals with autism this synchronization is impaired resulting to social communication difficulties.
LSD and Brain Synchronization: Initial research on LSD and brain synchronization in dogs shows that LSD can enhance social behaviors by increasing neural coherence and could be useful for human social interaction.
Beyond LSD: While LSD is the current focus of psychedelic research, other compounds like psilocybin and MDMA are also being studied for social and emotional challenges.
Ethical Considerations: Using psychedelics in medical and research settings requires careful ethical thinking especially around vulnerable populations like children with autism and long term effects of these treatments.
Alternative Therapies: Non-psychedelic mushrooms like Lion’s Mane and Reishi are alternative ways to enhance brain health and emotional regulation and can be potential adjuncts for developmental disorders like autism.
Future of Autism Treatment: While the psychedelics field is promising for autism treatment more research is needed around long term effects, safety and ethical administration before it becomes part of clinical practice.

Previous article Next article